EC Number | Application | Comment | Organism |
---|---|---|---|
1.8.7.1 | medicine | potential target for the development of antituberculosis agents | Mycobacterium tuberculosis |
EC Number | Cloned (Comment) | Organism |
---|---|---|
1.8.7.1 | expressed in Escherichia coli | Mycobacterium tuberculosis |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
1.8.7.1 | hanging drop vapour diffusion method using 0.1 M Tris-HCl, pH range 8.2-8.7, 0.2 M MgCl2, and 30% polyethylene glycol 4000 | Mycobacterium tuberculosis |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
1.8.7.1 | C161A | catalytically impaired mutant, tested in an assay using the nonphysiological electron donor methyl viologen and sulfite as substrate | Mycobacterium tuberculosis |
1.8.7.1 | C161S | catalytically impaired mutant, tested in an assay using the nonphysiological electron donor methyl viologen and sulfite as substrate | Mycobacterium tuberculosis |
1.8.7.1 | Y69A | catalytically impaired mutant, tested in an assay using the nonphysiological electron donor methyl viologen and sulfite as substrate | Mycobacterium tuberculosis |
1.8.7.1 | Y69F | catalytically impaired mutant, tested in an assay using the nonphysiological electron donor methyl viologen and sulfite as substrate | Mycobacterium tuberculosis |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
1.8.7.1 | [4Fe-4S] center | - |
Mycobacterium tuberculosis |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.8.7.1 | Mycobacterium tuberculosis | P9WJ03 | - |
- |
1.8.7.1 | Mycobacterium tuberculosis H37Rv | P9WJ03 | - |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
1.8.7.1 | Ni2+-nitrilotriacetic acid affinity matrix and Q-Sepharose column chromatography | Mycobacterium tuberculosis |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
1.8.7.1 | additional information | - |
the enzyme has a specific activity of 2.0 units/mg protein | Mycobacterium tuberculosis |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.8.7.1 | additional information | NirA has a pronounced preference for sulfite over nitrite as substrate | Mycobacterium tuberculosis | ? | - |
? | |
1.8.7.1 | additional information | NirA has a pronounced preference for sulfite over nitrite as substrate | Mycobacterium tuberculosis H37Rv | ? | - |
? | |
1.8.7.1 | sulfite + methyl viologen | - |
Mycobacterium tuberculosis | sulfide + ? | - |
? | |
1.8.7.1 | sulfite + methyl viologen | - |
Mycobacterium tuberculosis H37Rv | sulfide + ? | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
1.8.7.1 | monomer | x-ray crystallography | Mycobacterium tuberculosis |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.8.7.1 | ferredoxin-dependent sulfite reductase | - |
Mycobacterium tuberculosis |
1.8.7.1 | NirA | - |
Mycobacterium tuberculosis |
1.8.7.1 | siroheme- and [Fe4-S4]-dependent NirA | - |
Mycobacterium tuberculosis |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.8.7.1 | siroheme | - |
Mycobacterium tuberculosis |